Balaji R Opposition, Elexacaftor, (201737015848)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Quabodepistat, (201737004817)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Bedaquiline Long Acting, (202017005443)
Countries: India Date: 2023
-
DR. C. MANIVANNAN opposition, Upadacitinib [RINVOQ], (4759/DELNP/2012)
Countries: India Date: 2023
-
NEHA SAHU opposition, Upadacitinib [RINVOQ], (4759/DELNP/2012)
Countries: India Date: 2023
-
Dr. C. Manivannan opposition, Tirzepatide, ( 202017050717)
Countries: India Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Lenacapavir, (WO/2014/134566)
Countries: Thailand Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Baricitinib, (WO/2009/114512)
Countries: Thailand Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Delamanid, (WO/2007/013477)
Countries: Thailand Date: 2023
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (VN1-2021-07603 / WO/2021/250648)
Countries: Viet Nam Date: 2023